Clinical Trial Update: Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating quetiapine fumarate as monotherapy for maintenance treatment in adults with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Quetiapine fumarate (Quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED